Nano-x Imaging Ltd · NASDAQ:NNOX
Nano-x Imaging — J.P. Morgan Healthcare Conference 2021
42 slides from Nano-x Imaging's conference presentation, January 2021
Slide 1: Dawn of early detection healthcare
Dawn of early OVERVIEW detection healthcare EARLY DETECTION THE BARRIER BREAKING THROUGH THE TECH NANOX ARC NANOX BENEFITS RSNA 2020 OPINIONS OUR PLAN BUSINESS MODEL DEPLOYMENTS NANOX CLOUD FDA PARTNERSHIPS Corporate TEAM Presentation January 2021 SUMMARY 1
Slide 2: Disclaimers
Disclaimers conditions, general conditions in the medical technology and imaging Nothing contained in this presentation is, or should be construed as, a industries; the impact of the COVID-19 pandemic on the Company's business recommendation, promise or representation by the presenter or NANO-X oper
Slide 3: Nanox at a glance
Nanox at a glance The What Unmet need Game changing tech Disruptive business model Nanox aims to build a Large deficit of medical A novel digital X-Ray source Executed contracts for 5,150 ILLUSTRATIVE MODEL global infrastructure for imaging systems due to replacing an analog X-Ray that has units pen
Slide 4: Preventive screening
Preventive screening OVERVIEW Early detection is key to EARLY DETECTION THE BARRIER preventive healthcare. BREAKING THROUGH THE TECH NANOX ARC NANOX BENEFITS RSNA 2020 Treatable conditions, such as cancer, OPINIONS cardiovascular failures and others are often OUR PLAN BUSINESS MODEL diagnosed too la
Slide 5: Early detection remains theoretical
Early detection remains theoretical OVERVIEW 2/3 of the world’s EARLY DETECTION THE BARRIER population have no BREAKING THROUGH THE TECH NANOX ARC NANOX BENEFITS meaningful access to RSNA 2020 OPINIONS medical imaging OUR PLAN BUSINESS MODEL DEPLOYMENTS The majority of the remaining 1/3 NANOX CLOUD
Slide 6: Why?
Why? OVERVIEW Medical imaging EARLY DETECTION THE BARRIER systems are too BREAKING THROUGH THE TECH NANOX ARC NANOX BENEFITS expensive and RSNA 2020 OPINIONS complex for mass OUR PLAN BUSINESS MODEL DEPLOYMENTS deployment. NANOX CLOUD FDA PARTNERSHIPS TEAM SUMMARY 6
Slide 7: The key inhibitor
The key inhibitor OVERVIEW X-Ray source technology EARLY DETECTION THE BARRIER has not changed since its BREAKING THROUGH THE TECH NANOX ARC NANOX BENEFITS discovery over 120 years RSNA 2020 OPINIONS ago OUR PLAN BUSINESS MODEL DEPLOYMENTS NANOX CLOUD FDA PARTNERSHIPS TEAM SUMMARY 7 Wilhelm Conrad R
Slide 8: The hot cathode
The hot cathode OVERVIEW EARLY DETECTION Current day X-Ray tube THE BARRIER Analog X-Ray source BREAKING THROUGH THE TECH Heats up a metal filament NANOX ARC to 2,000° Celsius to produce the electron NANOX BENEFITS streams necessary for X- RSNA 2020 Ray emission OPINIONS Electrons OUR PLAN BUSINESS
Slide 9: Main contributor to high-cost of imaging systems
Main contributor to high-cost of imaging systems OVERVIEW EARLY DETECTION THE BARRIER BREAKING THROUGH THE TECH NANOX ARC NANOX BENEFITS RSNA 2020 OPINIONS The legacy OUR PLAN BUSINESS MODEL analog X-Ray DEPLOYMENTS NANOX CLOUD FDA PARTNERSHIPS source Requires extremely high-voltage, complex TEAM me
Slide 10: The Nanox paradigm
The Nanox paradigm OVERVIEW EARLY DETECTION Driving higher THE BARRIER rates of medical BREAKING THROUGH Which we expect prevention through THE TECH will enable early-detection. NANOX ARC NANOX BENEFITS significantly higher Will result in lower cost availability of RSNA 2020 OPINIONS A fundamental a
Slide 11: Introducing the novel Nanox X-Ray source
Introducing the novel Nanox X-Ray source OVERVIEW Novel silicon-based, EARLY DETECTION THE BARRIER BREAKING THROUGH low voltage, nano- THE TECH NANOX ARC scale cold cathode NANOX BENEFITS RSNA 2020 Generating the electrons streams OPINIONS needed for X-Ray via cold field- OUR PLAN emission technolog
Slide 12: Nanox MEMs X-Ray technology
Nanox MEMs X-Ray technology NANOX CLEAN ROOM • Technology originally • Nanox-owned (JAPAN) OVERVIEW manufacturing facilities in developed by Sony and its partners to achieve a higher Japan EARLY DETECTION quality image for screens THE BARRIER and monitors • Signed agreement with SK Telecom for colla
Slide 13: Tech transformation
Tech transformation OVERVIEW EARLY DETECTION From To THE BARRIER BREAKING THROUGH THE TECH NANOX ARC NANOX BENEFITS RSNA 2020 OPINIONS OUR PLAN BUSINESS MODEL DEPLOYMENTS NANOX CLOUD FDA PARTNERSHIPS TEAM One metal filament heated to 2,000° Celsius 100 Million nano-cones field on a silicon requiring
Slide 14: The Nanox tube
The Nanox tube OVERVIEW EARLY DETECTION THE BARRIER BREAKING THROUGH Commercially available THE TECH NANOX ARC Digital X-Ray source NANOX BENEFITS RSNA 2020 OPINIONS The Nanox Silicon OUR PLAN BUSINESS MODEL DEPLOYMENTS MEMs cold cathode NANOX CLOUD FDA PARTNERSHIPS TEAM SUMMARY 14
Slide 15: The Nanox tube
The Nanox tube OVERVIEW Significantly smaller EARLY DETECTION THE BARRIER Substantially more cost effective BREAKING THROUGH THE TECH NANOX ARC NANOX BENEFITS RSNA 2020 OPINIONS OUR PLAN LEGACY TUBE NANOX BUSINESS MODEL DEPLOYMENTS ~$100 estimated cost in mass- $150,000 average cost NANOX CLOUD prod
Slide 16: Clinical quality imaging
Clinical quality imaging Nanox I kVp: 50 I mAs: 0.4 I Commercial device I kVp: 60 I mAs: 3.5 OVERVIEW EARLY DETECTION THE BARRIER BREAKING THROUGH THE TECH NANOX ARC NANOX BENEFITS RSNA 2020 OPINIONS OUR PLAN BUSINESS MODEL DEPLOYMENTS NANOX CLOUD FDA PARTNERSHIPS TEAM kVp - Kilovolt Peak. kVp is th
Slide 17: Clinical quality imaging
Clinical quality imaging Shoulder OVERVIEW EARLY DETECTION THE BARRIER 3D Image Reconstruction BREAKING THROUGH THE TECH NANOX ARC NANOX BENEFITS RSNA 2020 OPINIONS OUR PLAN BUSINESS MODEL DEPLOYMENTS NANOX CLOUD FDA PARTNERSHIPS TEAM SUMMARY 17 NANOX X-Ray TUBE 40Kv, 2.5mA
Slide 18: The Nanox.ARC 3D computerized tomosynthesis
The Nanox.ARC 3D computerized tomosynthesis OVERVIEW EARLY DETECTION THE BARRIER New breed of medical imaging BREAKING THROUGH using revolutionary X-ray source THE TECH NANOX ARC Results in lower cost, less complex, and smaller imaging NANOX BENEFITS system RSNA 2020 OPINIONS Aims to democrati
Slide 19: Multi-source imaging
The benefits Multi-source imaging OVERVIEW EARLY DETECTION THE BARRIER BREAKING THROUGH THE TECH NANOX ARC NANOX BENEFITS RSNA 2020 OPINIONS OUR PLAN BUSINESS MODEL DEPLOYMENTS Enables simple architecture NANOX CLOUD FDA Stationary sources PARTNERSHIPS Minimal moving parts TEAM Energy efficient duty
Slide 20: Multi-modalities
The benefits Multi-modalities OVERVIEW EARLY DETECTION THE BARRIER BREAKING THROUGH THE TECH NANOX ARC NANOX BENEFITS RSNA 2020 OPINIONS OUR PLAN BUSINESS MODEL DEPLOYMENTS NANOX CLOUD Single source 2D X- 3-Source 3D 11-Source Axial Imaging ray Fluoroscopy FDA PARTNERSHIPS TEAM SUMMARY 20
Slide 21: RSNA 2020
RSNA 2020 OVERVIEW • Live streaming EARLY DETECTION presentation was THE BARRIER performed with global BREAKING THROUGH audience of thousands THE TECH NANOX ARC • Nanox single source live NANOX BENEFITS imaging RSNA 2020 OPINIONS • Nanox.ARC multi-source OUR PLAN live imaging BUSINESS MODEL DEPLOYME
Slide 22: RSNA 2020
RSNA 2020 Nanox single source live imaging and Nanox multi-source 3D tomosynthesis OVERVIEW radiologists diagnostics EARLY DETECTION THE BARRIER BREAKING THROUGH THE TECH NANOX ARC NANOX BENEFITS RSNA 2020 OPINIONS OUR PLAN BUSINESS MODEL DEPLOYMENTS NANOX CLOUD On the left - the hand of Ran Poliaki
Slide 23: Post-RSNA Press
Post-RSNA Press OVERVIEW EARLY DETECTION THE BARRIER BREAKING THROUGH THE TECH NANOX ARC NANOX BENEFITS RSNA 2020 OPINIONS OUR PLAN BUSINESS MODEL DEPLOYMENTS NANOX CLOUD FDA PARTNERSHIPS TEAM SUMMARY 23
Slide 24: Our plan
Our plan OVERVIEW Disrupt the imaging market • Increase significantly medical imaging EARLY DETECTION availability THE BARRIER with a global service • Deploy 15,000 units globally by YE2024 BREAKING THROUGH infrastructure for medical subject to Company financing & regulatory THE TECH NANOX ARC imagi
Slide 25: Timeline and key milestones
Timeline and key milestones 8 Years Q3 2020 OVERVIEW Secures $79M MBO by Japanese R&D team and investment from EARLY DETECTION establishment of Nanox; strategic investors, including Foxconn, Manufacturing Sony and focus on medical from H1 2021 THE BARRIER Industrial Alliance, agreement with partners
Slide 26: Addressable market
Addressable market Expansion of the $21 Billion global medical imaging market through shift from CAPEX to MSaaS model OVERVIEW We do not compete over market share, EARLY DETECTION The X-Ray-based imaging market 2021-2024 THE BARRIER Nanox addresses the market segments we expand the total market BREA
Slide 27: Flexible business model to drive adoption
Flexible business model to drive adoption MSaaS Pricing model & minimum annual service fee OVERVIEW ILLUSTRATIVE MODEL • Pay-per-scan service business model EARLY DETECTION POTENTIAL ANNUAL RECURRING REVENUE ASSUMING THE 5,150 • Nanox covers CAPEX investment in systems and deployment CONTRACTED UNIT
Slide 28: Contracted deployments
Contracted deployments OVERVIEW Current contracts for deals - 5,150 units EARLY DETECTION (Pending local regulatory approval) • Australia, NZ, Norway - 1,000 units THE BARRIER • Taiwan, Singapore - 500 units BREAKING THROUGH • Italy - 500 units THE TECH • Spain - 420 units • Mexico and Guatemala - 6
Slide 29: Selected customer profiles
Selected customer profiles OVERVIEW SPI Medical, S.A. de C.V. (Mexico) EARLY DETECTION THE BARRIER • SPI Medical, S. A. de C.V. is a distributor of specialty pharma products and medical devices, operating with global leaders BREAKING THROUGH such as Abbott, Merck, Bayer and Eli Lilly, and medical TH
Slide 30: Selected customer profiles
Selected customer profiles OVERVIEW Promedica Bioelectronics s.r.l. (Italy) EARLY DETECTION THE BARRIER • Promedica Bioelectronics s.r.l. has over 25 years of experience representing diagnostic imaging vendors such BREAKING THROUGH as Fujifilm, Siemens Medical Systems and GE Healthcare THE TECH • Al
Slide 31: USA
USA OVERVIEW EARLY DETECTION Strategic collaboration with USARAD THE BARRIER BREAKING THROUGH • Over 250+ U.S. certified radiologists organization THE TECH • Providing online, remote radiology services across the U.S. NANOX ARC • 25% owned by Siemens Healthineers NANOX BENEFITS RSNA 2020 OPINIONS •
Slide 32: The Nanox infrastructure management platform
The Nanox infrastructure management platform Increasing availability of medical imaging systems solves only half of the problem OVERVIEW Purpose built proprietary radiology software platform streamlines operations and analytics EARLY DETECTION THE BARRIER • Radiology diagnostics remain a significant
Slide 33: The Nanox.CLOUD
A central backbone of our imaging infrastructure that will The Nanox.CLOUD provide the ability to scale with connectivity to robust services OVERVIEW • Built ground-up with automation, privacy and security in mind EARLY DETECTION • Expected to be HIPPA and GDPR compliant THE BARRIER • Enables integr
Slide 34: Regulatory clearance
Regulatory clearance FDA OVERVIEW • We expect to take a multi-step approach to the o We do not believe the Nanox X-ray source (the EARLY DETECTION regulatory clearance process: core component of the Nanox.ARC) will THE BARRIER o Submitted a 510(K) application in January 2020 require a separate regul
Slide 35: Global partnerships
Global partnerships OVERVIEW Nanox’s cloud-based service will enable medical imaging services globally through its EARLY DETECTION partnerships THE BARRIER BREAKING THROUGH Strategic Partners AI & Image Transfer Deployments THE TECH NANOX ARC 5G, MEMs manufacturing Cancer detection United States NAN
Slide 36: The team
A strong execution team with decades of relevant experience and proven track The team record of large-scale global projects, medical business expertise and bringing innovation to market OVERVIEW EARLY DETECTION THE BARRIER BREAKING THROUGH THE TECH NANOX ARC NANOX BENEFITS RSNA 2020 OPINIONS OUR PLA
Slide 37: Advisory board
Advisory board OVERVIEW EARLY DETECTION THE BARRIER BREAKING THROUGH THE TECH NANOX ARC Morry Blumenfeld Prof. Geoffrey D. Rubin Prof. Norbert Pelc Ruth Atherton, Ph.D., J,D. Dr. Rafael Grossman NANOX BENEFITS RSNA 2020 OPINIONS OUR PLAN BUSINESS MODEL DEPLOYMENTS NANOX CLOUD FDA Michael Jackman Dr.
Slide 38: Progress since August IPO
Progress since August IPO OVERVIEW October September EARLY DETECTION Announces agreement with January Signs agreement with SPI Ambra Health to enable Collaborates with THE BARRIER Medical for the deployment of image access to US USARAD on radiology 630 Nanox.ARC units across BREAKING THROUGH hospita
Slide 39: Summary
Summary OVERVIEW • Nanox is developing a digital source x-ray • We believe that the industry should migrate to an technology enabling a new generation of imaging open platform “App Store” model with multiple EARLY DETECTION devices that could significantly reduce the costs of diagnostics support app
Slide 40: Thank You
OVERVIEW EARLY DETECTION THE BARRIER BREAKING THROUGH THE TECH NANOX ARC NANOX BENEFITS RSNA 2020 OPINIONS OUR PLAN BUSINESS MODEL Thank You DEPLOYMENTS NANOX CLOUD FDA PARTNERSHIPS TEAM SUMMARY 40
Slide 41: Enabling a system-level quantum leap
Enabling a system-level quantum leap OVERVIEW From To EARLY DETECTION THE BARRIER BREAKING THROUGH THE TECH NANOX ARC NANOX BENEFITS RSNA 2020 OPINIONS OUR PLAN BUSINESS MODEL DEPLOYMENTS NANOX CLOUD Analog Digital Single-source Multi-source FDA Single-modality Multi-modalities PARTNERSHIPS Large an
Slide 42: Multi-modalities
The benefits Multi-modalities Single source 2D X-ray 3-Source 3D Fluoroscopy OVERVIEW EARLY DETECTION 11-Source Axial Imaging THE BARRIER BREAKING THROUGH THE TECH NANOX ARC NANOX BENEFITS RSNA 2020 OPINIONS OUR PLAN BUSINESS MODEL DEPLOYMENTS NANOX CLOUD FDA PARTNERSHIPS TEAM SUMMARY 42
Nano-X Imaging — J.P. Morgan Healthcare Conference 2021 on 6ix